SYNLOGIC, INC. Other Restructuring Costs
SYNLOGIC, INC. (SYBX) reported Other Restructuring Costs of $122.00 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2017-08-04
- SYNLOGIC, INC. other restructuring costs for the quarter ending 2017-06-30 was $122.00K.
- SYNLOGIC, INC. other restructuring costs for the quarter ending 2017-03-31 was $2.35M.
- SYNLOGIC, INC. other restructuring costs for the quarter ending 2016-06-30 was $0.00.
- SYNLOGIC, INC. other restructuring costs for the quarter ending 2016-03-31 was $0.00.
| Period end | Other Restructuring Costs 3 month | Other Restructuring Costs 6 month | Other Restructuring Costs 12 month | Other Restructuring Costs 12 month as first filed |
|---|---|---|---|---|
| 2017-06-30 | $122.00K 10-Q · filed 2017-08-04 | $2.48M 10-Q · filed 2017-08-04 | ||
| 2017-03-31 | $2.35M 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $1.50M 10-Q · filed 2017-08-04 | $1.49M 10-K · filed 2017-03-15 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |